Transcranial sonography in Parkinson’s disease
https://doi.org/10.20538/1682-0363-2018-1-15-23
Abstract
Despite a broad discussion of the results of ultrasound in Parkinson disease, the dynamics of hyperechoinality of the substantia nigra based on the clinical forms and stages of the disease remains controversial.
The purpose of this study is to study thechanges in the substantia nigra of the brain based on the clinical form and stage using an ultrasound in patients with Parkinson’s disease.
Materials and methods. The study involved 100 patients with Parkinson’s disease whom were scanned using transcranial sonography through the temporal window with the use of ultrasound scanner Toshiba Aplio 500 (Japan) with a sector transducer with a frequency of 2,5 мGz.
Results. It was found that the asymmetric variant of changes in the black substance prevailed in each clinical group of patients and was more often recorded with akinetic-rigid form and the greatest changes were observed in the stages II and III of the disease.
About the Authors
I. V. Bayborodina
Clinical Diagnostic Center (CDC) “RITM”.
Russian Federation
Russian Federation
Bayborodina Irina V., Doctor of Ultrasonic Diagnostics, Head of the Department of Ultrasound Diagnostics.
32/2, Str. Korabelnaya, Ulan-Ude, Republic of Buryatia, 670000.
V. D. Zavadovskaya
Siberian State Medical University (SSMU) .
Russian Federation
Zavadovskaya Vera D., DM, Professor, Head of the Department of Radiation Diagnosis and Radiotherapy. 2, Moscow Tract, 634050, Tomsk.
Russian Federation
Zavadovskaya Vera D., DM, Professor, Head of the Department of Radiation Diagnosis and Radiotherapy. 2, Moscow Tract, 634050, Tomsk.
N. G. Zhukova
Siberian State Medical University (SSMU) .
Russian Federation
Russian Federation
Zhukova Natalia G., DM, Professor, Department of Neurology and Neurosurgery.
2, Moscow Tract, 634050, Tomsk.
I. A. Zhukova
Siberian State Medical University (SSMU) .
Russian Federation
Russian Federation
Zhukova Irina A., PhD, Associate Professor, Department of Neurology and Neurosurgery.
2, Moscow Tract, 634050, Tomsk.
T. V. Fetisova
Clinical Diagnostic Center (CDC) “RITM”.
Russian Federation
Russian Federation
Fetisovа Tatiana V., Neurologist.
32/2, Str. Korabelnaya, Ulan-Ude, Republic of Buryatia, 670000.
V. N. Yazhinova
Clinical Diagnostic Center (CDC) “RITM”.
Russian Federation
Russian Federation
Yazhinova Faith N., Neurologist.
32/2, Str. Korabelnaya, Ulan-Ude, Republic of Buryatia, 670000.
T. D. Ochirova
Republican Clinical Hospital named after N.A. Semashko .
Russian Federation
Russian Federation
Ochirova Tatiana D., Neurologist.
12, Pavlova Str., Ulan-Ude, Republic of Buryatia, 670031.
A. V. Danilenko
Clinical Diagnostic Center (CDC) “RITM”.
Russian Federation
Russian Federation
Danilenko Andrey V., Neurologist.
32/2, Str. Korabelnaya, Ulan-Ude, Republic of Buryatia, 670000.
A. V. Basanova
Clinical Diagnostic Center (CDC) “RITM”.
Russian Federation
Basanova Anna V., Chief Doctor. 32/2, Str. Korabelnaya, Ulan-Ude, Republic of Buryatia, 670000.
Russian Federation
Basanova Anna V., Chief Doctor. 32/2, Str. Korabelnaya, Ulan-Ude, Republic of Buryatia, 670000.
L. A. Zangeeva
Clinical Diagnostic Center (CDC) “RITM”.
Russian Federation
Russian Federation
Zangeeva Leanora A., General Director.
32/2, Str. Korabelnaya, Ulan-Ude, Republic of Buryatia, 670000.
References
1. Zhukova I.A., Zhukova N.G., Izhboldina O.P., Nikitina M.A., Alifirova V.М. Analysis of methods for assessing olfaction in patients with Parkinson’s disease. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. Nevrologiya i psikhiatriya pozhilogo vozrasta – Journal of Neurology and Psychiatry. S.S. Korsakov. Neurology and psychiatry of advanced age. 2015; 2: 47–52 (in Russ.).
2. Becker С., Berg D. Neuroimaging in basal ganglia disorders: Perspectives for transcranial ultrasound. Mov. Disord. 2001; 16: 23–32.
3. Berg D., Godau J., Walter U. Transcranial sonography in movement disorders. Lancet Neurol. 2008; 7: 1044–1055.
4. Puts I., Berg D., Maeurer M. Transcranial sonography of the brain parenchyma: Comparison of B-mode imaging and tissue harmonic imaging. Ultrasound. Med. Biol. 2000; 26: 189–194.
5. Berg D., Hochstrasser H. Iron metabolism in parkinsonian syndromes. Mov. Disord. 2011; 21: 1299–1310.
6. Весk G., Seuferl J., Bogdahn U. Degeneration of substantia nigra in chronic Parkinsons disease visualized by transkranial color-coded real-time sonography. Neurology. 2013; 45; 182–184.
7. Lyoo C.H., Ryu Y.H., Lee M.S.J. Cerebral cortical areas in which thickness correlates with severity of motor deficits of Parkinson’s disease. Neurology. 2011; 258: 1871–1876.
8. Truphanov A.G., Litvinenko I.V., Voronkov L.V., Rameshvilli T.E. Dementia in Parkinson’s disease: the role of atrophic cortical changes and the possibility of prognosis with the help of magnetic resonance morphometry. Vestnik Rossiyskoy voyenno-meditsinskoy akademii – Bulletin of the Russian Military Medical Academy. 2012; 3: 116–123 (in Russ.).
9. Chechetkin A.O. Transcranial ultrasound scanning of the brain in Parkinson’s disease. Visualization in the clinic. Vizualizatsiya v klinike – Visualization in the clinic. 2000; 17: 45–48 (in Russ.).
10. Berg D., Behnke S., Walter U. Application of transcranial Sonography in extrapyramidal disorder: Updated Recommendation. Ultraschall Med. 2009; 27: 12–19.
11. Becker С., Berg D. Neuroimaging in basal ganglia disorders: Perspectives for transcranial ultrasound. Mov. Disord. 2011; 16: 23–32.
12. Berg D., Roggendorf W., Schroeder U. Echogenicity of the substantia nigra: Association with increased iron content and marker forsusceptibility to nigrostriatal injury. Arch. Neurol. 2002; 59: 999–1005.
13. Morrish P.K., Sawle G.V., Brooks D.J. An 18F-dopa PET and clinical study of the rate of progression in Parkinson’s disease. Brain. 1996; 119: 223–591.
14. Berg D. Disturbans of iron metabolism as a contributing factor to SN hiperechogenicity in Parkinsons disease: implicaty ons for idiopathic end monogenetic forms. Neurogem. Res. 2010; 32: 1646–1654.
15. Fedotova E.Yu., Chechetkin A.O., Shadrina M.I. Transcranial sonography in Parkinson’s disease. Zhurnal nevrologiya i psikhiatriya – Journal of Neurology and Psychiatry. 2011; 111: 49–55 (in Russ.).
16. Golubev V.L., Levin Ya.I., Vein A.M. Parkinson’s disease and Parkinson’s syndrome. M.: MEDpress-Inform Publ., 2010: 416 (in Russ.).
17. Razdorskaya V.V., Yudina G.K., Voskresenskaya O.N. Clinical efficiency of symptomatic therapy of an atypical variant of hemiparkinsonism-hemiatrophy. 15 Congress of the European Federation of Neurological Societies EFNS, 2011: 522.
18. Berg D., Siefker C., Becker G. Echogenicity of the substantia nigra in Parkinson’s disease and its relation to clinical findings. J. Neurol. 2001; 8: 429–433.
19. Yudina V.V., Voskresenskaya O.N., Yudina G.K. Peculiarities of poststroke variant of vascular parkinsonism. Actual questions of practical neurosurgery: мaterials of the jubilee scientific and practical conference. Balakovo, 2009: 172–174 (in Russ.).
20. Berg D., Behnke S., Walter U. Application of transcranial Sonography in extrapyramidal disorder: Updated Recommendation. Ultraschall. Med. 2009; 27: 12–19.
21. Berg D., Roggendorf W., Schroder U.Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibilit to nigrostriatal injury. Arch. Neurol. 2012; 59: 999–1050.
Review
For citations:
Bayborodina I.V., Zavadovskaya V.D., Zhukova N.G., Zhukova I.A., Fetisova T.V., Yazhinova V.N., Ochirova T.D., Danilenko A.V., Basanova A.V., Zangeeva L.A. Transcranial sonography in Parkinson’s disease. Bulletin of Siberian Medicine. 2018;17(1):15-23. (In Russ.) https://doi.org/10.20538/1682-0363-2018-1-15-23
Views:
3202
Email this article 